Which one is more effective in treating alopecia areata, ritexitinib or baricitinib?
Ritlecitinib (Ritlecitinib) and baricitinib (baricitinib) are both drugs for the treatment of alopecia areata, but their efficacy and indications are different.
Ritexitinib is an oral small molecule drug that modulates the function of the immune system by inhibiting the activity of specific immune cells, thereby alleviating the symptoms of alopecia areata. Clinical data shows that after 24 weeks of ritexitinib treatment, 31% of patients with alopecia areata had a SALT score equal to or greater than 20, which means that the hair coverage area of u200bu200bthese patients has returned to more than 80%, which is much higher than that of the placebo group. In addition, the study also included patients with alopecia areata aged 12-17 years old, indicating that its safety is relatively high. However, the use of ritexitinib is not recommended in patients with severe hepatic impairment.

Baricitinib is an anti-rheumatic drug that has anti-inflammatory and anti-rheumatic effects and can also be used to treat alopecia areata. Clinical data show that after 36 weeks of using baricitinib, patients with alopecia areata in the 2-mg and 4-mg groups had better improvement results than the placebo group, and no new adverse reactions occurred. For more than 50% of patients with alopecia areata, baricitinib has demonstrated good efficacy and safety. In addition, baricitinib 4 mg appears to be the most effective therapy based on mean changes in SALT scores.
In general, both ritexitinib and baricitinib are effective in treating alopecia areata, but which one is more effective may vary depending on individual differences. When choosing a drug, it should be based on the patient's specific situation and the doctor's recommendations. At the same time, in addition to drug treatment, patients with alopecia areata should also pay attention to their daily diet and nursing care, such as eating more foods with high protein content and vitamin C-rich foods, and resting in bed as much as possible to avoid staying up late for long periods of time.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)